Literature DB >> 19203829

Overproduction of cyclin D1 is dependent on activated mTORC1 signal in nasopharyngeal carcinoma: implication for therapy.

Xiao-Ming Huang1, Cheng-Bo Dai, Zhong-Lin Mou, Li-Juan Wang, Wei-Ping Wen, Shu-Guang Lin, Geng Xu, Hua-Bin Li.   

Abstract

Activated mTOR was implicated to play a role in the carcinogenesis of nasopharyngeal carcinoma (NPC). However, the mechanism of activated mTOR/Complex1(mTORC1) signaling pathway in NPC development has not been well established. In this study, we correlated the expression of mTORC1 signal molecules and Cyclin D1 in NPC. We also investigated the effect of blocking mTORC1 signal with rapamycin and mTOR siRNA on Cyclin D1 expression in CNE-2 cells, as well as cell apoptosis and viability. We found a positive association of mTORC1 signal molecules and Cyclin D1 in NPC. Also, we found blockage mTORC1 inhibited Cyclin D1 expression in CNE-2 cells and enhanced cell apoptosis. Our results suggested that mTORC1 signal pathway might be a potential target for NPC therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203829     DOI: 10.1016/j.canlet.2009.01.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  Increased expression of aldehyde dehydrogenase 1 A1 in nasopharyngeal carcinoma is associated with enhanced invasiveness.

Authors:  Weijian Hou; Weiling He; Yuhuang Li; Renqiang Ma; Zhangfeng Wang; Xiaolin Zhu; Qingling Fu; Yihui Wen; Huabin Li; Weiping Wen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-27       Impact factor: 2.503

2.  Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.

Authors:  Jing Chen; Chun-Fang Hu; Jing-Hui Hou; Qiong Shao; Li-Xu Yan; Xiao-Feng Zhu; Yi-Xin Zeng; Jian-Yong Shao
Journal:  J Transl Med       Date:  2010-03-26       Impact factor: 5.531

3.  Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma.

Authors:  Chi Hang Wong; Herbert H Loong; Connie W C Hui; Cecilia P Y Lau; Edwin P Hui; Brigette B Y Ma; Anthony T C Chan
Journal:  Invest New Drugs       Date:  2013-08-24       Impact factor: 3.850

4.  Correlation of cyclin D1 expression with aggressive DNA pattern in patients with tobacco-related intraoral squamous cell carcinoma.

Authors:  Satya N Das; Pratima Khare; Manoj K Singh; Suresh C Sharma
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

5.  The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity.

Authors:  Yuan Zhang; Yu Liu; Yuan-Xian Yang; Jia-Hong Xia; Hong-Xiu Zhang; Hua-Bin Li; Chun-Zhao Yu
Journal:  J Exp Clin Cancer Res       Date:  2009-09-23

6.  Oncogenic roles of carbonic anhydrase IX in human nasopharyngeal carcinoma.

Authors:  Yi Sang; Li Wang; Jian-Jun Tang; Mei-Fang Zhang; Meng-Xia Zhang; Xia Liu; Ru-Hua Zhang; Tie-Bang Kang; Ming-Yuan Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

7.  Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.

Authors:  Ke-Feng Wang; Hang Yang; Wen-Qi Jiang; Su Li; Yu-Chen Cai
Journal:  Int J Mol Med       Date:  2015-10-16       Impact factor: 4.101

8.  Inhibition of GSK 3β activity is associated with excessive EZH2 expression and enhanced tumour invasion in nasopharyngeal carcinoma.

Authors:  Renqiang Ma; Yi Wei; Xiaoming Huang; Ran Fu; Xi Luo; Xiaolin Zhu; Wenbin Lei; Jugao Fang; Huabin Li; Weiping Wen
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

9.  Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells.

Authors:  Yang Xu; Ying Shi; Qi Yuan; Xuli Liu; Bin Yan; Ling Chen; Yongguang Tao; Ya Cao
Journal:  J Exp Clin Cancer Res       Date:  2013-11-13

10.  miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN.

Authors:  Mengyang Zhao; Rongcheng Luo; Yiyi Liu; Linyuan Gao; Zhaojian Fu; Qiaofen Fu; Xiaojun Luo; Yiyu Chen; Xiaojie Deng; Zixi Liang; Xin Li; Chao Cheng; Zhen Liu; Weiyi Fang
Journal:  Nat Commun       Date:  2016-04-20       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.